MSFBX
Price
$33.93
Change
-$0.00 (-0.00%)
Updated
May 9 closing price
Net Assets
2.66B
RWICX
Price
$64.58
Change
+$0.12 (+0.19%)
Updated
May 9 closing price
Net Assets
124.77B
Ad is loading...

MSFBX vs RWICX

Header iconMSFBX vs RWICX Comparison
Open Charts MSFBX vs RWICXBanner chart's image
Morgan Stanley Inst Global Franchise A
Price$33.93
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets2.66B
American Funds Capital World Gr&Inc R3
Price$64.58
Change+$0.12 (+0.19%)
VolumeN/A
Net Assets124.77B
MSFBX vs RWICX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSFBX vs. RWICX commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSFBX is a Buy and RWICX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWICX has more cash in the bank: 125B vs. MSFBX (2.66B). RWICX pays higher dividends than MSFBX: RWICX (1.34) vs MSFBX (0.43). MSFBX was incepted earlier than RWICX: MSFBX (23 years) vs RWICX (23 years). MSFBX (1.17) is less costly to investors than RWICX (1.06). MSFBX is a more actively managed with annual turnover of: 35.00 vs. RWICX (27.00). RWICX has a lower initial minimum investment than MSFBX: RWICX (250) vs MSFBX (1000). RWICX annual gain was more profitable for investors over the last year : 1.86 vs. MSFBX (-0.56). RWICX return over 5 years is better than : 49.43 vs. MSFBX (31.68).
MSFBXRWICXMSFBX / RWICX
Total Expense Ratio1.171.06110%
Annual Report Gross Expense Ratio1.171.06110%
Fund Existence23 years23 years-
Gain YTD4.1442.727152%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.66B125B2%
Annual Yield % from dividends0.431.3433%
Returns for 1 year-0.561.86-30%
Returns for 3 years15.5729.4953%
Returns for 5 years31.6849.4364%
Returns for 10 years66.1540.26164%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SVXLX57.58N/A
N/A
Smead International Value Inv
MUEAX34.15N/A
N/A
MFS Blended Research Core Equity A
BGRUX89.76N/A
N/A
Baron Growth R6
BALSX9.29N/A
N/A
BlackRock U.S. Insights Lon/Shr Eq Inv A
MGOCX34.43-0.11
-0.32%
NYLI WMC Enduring Capital Class C